Collecting data on side effects of proton therapy for cancer treatment
Official title: Data Collection to Assess Acute and Late Normal Tissue Sequelae in Proton Therapy for Adults
Run by M.D. Anderson Cancer Center · NCT00991094 · Data updated 2026-11-12
This study is trying to learn about the side effects that cancer patients experience after receiving proton therapy to help improve future treatments.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 5000 (estimated) |
| Sponsor | M.D. Anderson Cancer Center Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Houston, Texas) |
| Status | Recruiting |
| Started | May 27, 2005 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | June 12, 2026 |
| Trial ID | NCT00991094 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include patients scheduled for proton therapy at M.D. Anderson Cancer Center.
✕Probably not a fit
Patients who are unable or unwilling to attend the required follow-ups may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to gather information on the acute and late side effects experienced by patients undergoing proton therapy for various types of cancer, including breast, esophageal, and head and neck carcinomas. Researchers will collect detailed data on treatment plans and radiation dose distributions to better understand the relationship between these factors and normal tissue responses. Patients will be monitored weekly during treatment and for up to 90 days post-treatment, with quality-of-life assessments conducted through questionnaires. The goal is to refine predictions of side effects and improve future treatment protocols.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of proton therapy's safety profile and improve patient outcomes by predicting and mitigating side effects.
How similar studies have gone: Other studies have shown promise in assessing treatment-related toxicities, but this specific approach to proton therapy is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * All patients scheduled for radiation treatment with protons at UTMDACC are eligible for this protocol * Patients must sign a study-specific consent form prior to study entry Exclusion Criteria: * Patients who are unable or unwilling to attend the required periodic follow-ups either at M.D. Anderson or at a different site
Where it's running
-
M D Anderson Cancer Center
Houston, Texas, United States Recruiting
Study contacts
- Principal investigator: Steven J Frank — M.D. Anderson Cancer Center
- Study coordinator: Steven J. Frank
- Email: sjfrank@mdanderson.org
- Phone: 713-563-2300
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
In-home cancer treatment with remote specialist support for patients in the Florida Panhandle
This program will try giving standard cancer treatments at home to people living in the Florida Panhandle and nearby areas to see if they prefer it and have better treatment satisfaction.
-
Vanguard: a new blood test approach to screen for multiple cancers
This study will test two different blood-based multi-cancer detection tests in adults 45–75 without cancer to see if they find cancers earlier than usual care.
-
Using fucoidan to prevent fatigue in cancer patients undergoing chemotherapy
This study tests if a seaweed supplement called fucoidan can help cancer patients undergoing chemotherapy feel less tired.
-
Genetic testing for cancer in diverse ethnic groups
This study is testing how genetic testing can help cancer patients from different ethnic backgrounds understand their risks and improve their personalized care.
-
Collecting blood samples to evaluate tests for early cancer detection
This study is collecting blood and tissue samples from people with and without cancer to see if new tests can help detect cancer earlier.
-
Couples Coping Together Against Cancer: A Feasibility and Acceptability Look
This observational study tests whether a brokered program for patients with cancer and their partners is feasible and acceptable, and whether it may reduce distress over time.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.